News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Senne Dillen

Advertisement

Senne Dillen is senior scientist Drug Substance and Drug Product Development.

Articles by Senne Dillen

Ribosome as part of an biological cell constructing messenger rna molecules - 3d illustration | Image Credit: ©Christoph Burgstedt - Stock.adobe.com

Delivering on the Potential of mRNA Therapeutics

ByDavid Ricketts ,Nevin Witman ,Phil Challis ,Senne Dillen ,Bernard Sagaert
April 15th 2023

The complexity of the RNA production process creates challenges.

Advertisement

Latest Updated Articles

  • Ribosome as part of an biological cell constructing messenger rna molecules - 3d illustration | Image Credit: ©Christoph Burgstedt - Stock.adobe.com
    Delivering on the Potential of mRNA Therapeutics

    Published: April 15th 2023 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment

2

West Launches New Prefillable Syringe System that Streamlines Biologic Delivery

3

Pharmapack Europe 2026: Sustainability, Specialization, and Digitalization in Packaging

4

The Shift from Containment to Protection: Packaging Trends Impacting Pharma

5

ACG Introduces SuperPod for Drug Protection and Sustainability

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us